Wednesday, April 07, 2021 11:56:59 PM
The FDA has authorized stem cell treatments for certain procedures. But USRM was operating outside those established guidelines. Without approval USRM was in violation of FDA policy meant to ensure public safety.
I work in medicine and have experienced the process of obtaining FDA approval for a procedure that involves a medical device (surgical implant). I have first hand knowledge. Without FDA approval you are in violation of the law - like it or not.
The FDA has changed their position numerous times in an attempt to maintain control. There is no need to rehash their arbitrary interpretation of law as it pertains to tissue transplants and SSP's. If you have read my previous posts you will see where I challenge the FDA.
It is up to the appellate court to determine whether summary judgment was justified. The injunction was the outcome. I find it hard to believe the appellate court would be willing to go beyond remanding the case back to the state supreme court. I would expect the injunction to remain until a final ruling is made as that would be most prudent.
My focus is on winning the appeal. If the injunction is lifted temporarily that would be great. But what USRM really needs is their day in court.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM